• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.

作者信息

Abouljoud M S, Levy M F, Klintmalm G B

机构信息

Transplantation Services, Baylor University Medical Center, Dallas, Texas 75246.

出版信息

Transplant Proc. 1995 Feb;27(1):1121-3.

PMID:7533360
Abstract
摘要

相似文献

1
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
Transplant Proc. 1995 Feb;27(1):1121-3.
2
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.
Transplant Proc. 1995 Feb;27(1):1114-6.
3
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.对初发肝移植受者进行的一项多中心、随机、前瞻性试验（LIS2T）的12个月随访分析，该试验比较了环孢素微乳剂（C2监测）和他克莫司。
Liver Transpl. 2006 Oct;12(10):1464-72. doi: 10.1002/lt.20802.
4
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.使用普乐可复（FK506）作为肝移植后难治性排斥反应的挽救治疗。美国多中心FK506肝脏研究组。
Transplant Proc. 1993 Feb;25(1 Pt 1):679-88.
5
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.肝移植后难治性排斥反应从环孢素转换为基于FK 506的免疫抑制治疗成功的预后因素。美国多中心FK 506肝脏研究组。
Transplant Proc. 1993 Feb;25(1 Pt 1):641-3.
6
FK 506 treatment of intractable rejection after liver transplantation.FK506治疗肝移植后难治性排斥反应
Transplant Proc. 1993 Aug;25(4):2686-7.
7
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.长期环孢素或FK 506治疗对稳定肝移植受者糖脂代谢的影响。
Transplant Proc. 1995 Feb;27(1):1136-9.
8
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.原位肝移植后的骨质流失：他克莫司与环孢素的比较
Transplant Proc. 1996 Jun;28(3):1738-40.
9
FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.FK506在降低心脏移植后急性排斥反应中的有效性：一项前瞻性随机研究。
J Heart Lung Transplant. 1997 Oct;16(10):1001-10.
10
Evaluation of clinical safety of conversion to Advagraf therapy in liver transplant recipients: observational study.肝移植受者转换为阿伐格雷夫治疗的临床安全性评估：观察性研究。
Transplant Proc. 2009 Jul-Aug;41(6):2184-6. doi: 10.1016/j.transproceed.2009.06.085.

引用本文的文献

1
Cardiovascular effects of immunosuppression agents.免疫抑制剂的心血管效应。
Front Cardiovasc Med. 2022 Sep 21;9:981838. doi: 10.3389/fcvm.2022.981838. eCollection 2022.
2
Importance of Hematopoietic Mixed Chimerism for Induction of Renal Allograft Tolerance in Nonhuman Primates.造血嵌合体对诱导非人类灵长类动物肾移植耐受的重要性。
Transplantation. 2019 Apr;103(4):689-697. doi: 10.1097/TP.0000000000002470.
3
Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.基于嵌合体的器官移植耐受性：临床前和临床研究
Clin Exp Immunol. 2017 Aug;189(2):190-196. doi: 10.1111/cei.12969. Epub 2017 Apr 20.
4
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.他克莫司在实体器官移植中的临床药代动力学与药效学
Clin Pharmacokinet. 2004;43(10):623-53. doi: 10.2165/00003088-200443100-00001.
5
Lipoprotein-apolipoprotein changes in renal transplant recipients.肾移植受者的脂蛋白-载脂蛋白变化
Lipids. 2002 Oct;37(10):967-74. doi: 10.1007/s11745-006-0988-x.
6
Calcineurin inhibitors and post-transplant hyperlipidaemias.钙调神经磷酸酶抑制剂与移植后高脂血症
Drug Saf. 2001;24(10):755-66. doi: 10.2165/00002018-200124100-00004.
7
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.他克莫司：其在器官移植管理中的药理学及治疗应用的进一步更新
Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.
8
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.关于在他克莫司免疫抑制下进行的原位肝移植，我们了解到了什么？对首批1000例患者的长期随访。
Ann Surg. 1999 Sep;230(3):441-8; discussion 448-9. doi: 10.1097/00000658-199909000-00016.
9
Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.他克莫司。其在器官移植管理中的药理学及临床疗效的最新进展。
Drugs. 1997 Dec;54(6):925-75. doi: 10.2165/00003495-199754060-00009.